Legend Biotech Corp (LEGN) stock
LEGNNasdaqPharmaceutical PreparationsFiscal year ends December 31
$16.11+0.12 (+0.75%)
Close on Nov 17, 2026Market cap $2.98BP/E –Yield –
Legend Biotech total assets
Total assets on the balance sheet at the end of each period.
Legend Biotech's total assets was $1.75B at Jun 30, 2026. For fiscal 2025 it was $1.73B, up 3.8% from the year before. The highest annual figure on record is $1.85B in fiscal 2023.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.73B | +3.8% |
| FY2024 | Dec 31, 2024 | $1.67B | -9.7% |
| FY2023 | Dec 31, 2023 | $1.85B | +38.9% |
| FY2022 | Dec 31, 2022 | $1.33B | +18.9% |
| FY2021 | Dec 31, 2021 | $1.12B | +55.0% |
| FY2020 | Dec 31, 2020 | $722.09M | +146.8% |
| FY2019 | Dec 31, 2019 | $292.62M | – |
Quarterly total assets
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $1.75B | +3.6% |
| Q1 FY2026 | Mar 31, 2026 | $1.60B | -1.2% |
| Q4 FY2025 | Dec 31, 2025 | $1.73B | +3.8% |
| Q3 FY2025 | Sep 30, 2025 | $1.71B | -1.3% |
| Q2 FY2025 | Jun 30, 2025 | $1.69B | -6.0% |
| Q1 FY2025 | Mar 31, 2025 | $1.62B | -9.0% |
| Q4 FY2024 | Dec 31, 2024 | $1.67B | -9.7% |
| Q3 FY2024 | Sep 30, 2024 | $1.74B | -5.6% |
| Q2 FY2024 | Jun 30, 2024 | $1.80B | -6.9% |
| Q1 FY2024 | Mar 31, 2024 | $1.78B | +33.4% |
| Q4 FY2023 | Dec 31, 2023 | $1.85B | +65.1% |
| Q3 FY2023 | Sep 30, 2023 | $1.84B | +110.2% |
| Q2 FY2023 | Jun 30, 2023 | $1.93B | +167.4% |
| Q4 FY2022 | Dec 31, 2022 | $1.33B | +354.8% |
| Q4 FY2021 | Dec 31, 2021 | $1.12B | – |
| Q2 FY2021 | Jun 30, 2021 | $875.13M | – |
| Q4 FY2020 | Dec 31, 2020 | $722.09M | – |
| Q4 FY2019 | Dec 31, 2019 | $292.62M | – |
See a number that looks wrong?